Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019
Article
[키워드] Admission
age
Analysis
average
baseline
Biomarker
C-reactive protein
changes in
clinical progression
clinically
Concentration
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infections
COVID-19 patient
COVID-19 patients
cut-off
determine
Disease progression
enrolled
eosinophil
evaluate the effect
ferritin
Future
hospitalisation
hospitalised
IgE
immune
Immunoglobulin
independent predictors
individual
inflammatory parameter
males
Negative predictive value
outcome
pandemic
parameter
Patient
patients
pilot study
Positive predictive value
predisposition
prognostic biomarker
Prognostic factor
progression
required
resource
risk factor
sensitivity
serum
severity
significantly lower
specificity
to define
total IgE.
were measured
were recorded
with COVID-19
worsened
worsening
[DOI] 10.1111/imj.15728 PMC 바로가기
[DOI] 10.1111/imj.15728 PMC 바로가기